Tzelepis, Fanny 
; Birdi, Harsimrat Kaur ; Jirovec, Anna ; Boscardin, Silvia Beatriz ; Souza, Christiano Tanese de; Hooshyar, Mohsen; Chen, Andrew; Sutherland, Keara; Parks, Robin J.; Werier, Joel; Diallo, Jean-Simon
Source: Molecular Therapy - Oncolytics. Unidade: ICB
Subjects: PARASITOLOGIA, IMUNOTERAPIA, VACINAS VIRAIS, RHABDOVIRIDAE, VÍRUS DE RNA, NEOPLASIAS, VETORES, ANTÍGENOS DE VÍRUS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TZELEPIS, Fanny et al. Oncolytic rhabdovirus vaccine boosts chimeric Anti-DEC205 priming for effective cancer immunotherapy. Molecular Therapy - Oncolytics, v. 19, p. 240-252, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.omto.2020.10.007. Acesso em: 09 nov. 2024.APA
Tzelepis, F., Birdi, H. K., Jirovec, A., Boscardin, S. B., Souza, C. T. de, Hooshyar, M., et al. (2020). Oncolytic rhabdovirus vaccine boosts chimeric Anti-DEC205 priming for effective cancer immunotherapy. Molecular Therapy - Oncolytics, 19, 240-252. doi:10.1016/j.omto.2020.10.007NLM
Tzelepis F, Birdi HK, Jirovec A, Boscardin SB, Souza CT de, Hooshyar M, Chen A, Sutherland K, Parks RJ, Werier J, Diallo J-S. Oncolytic rhabdovirus vaccine boosts chimeric Anti-DEC205 priming for effective cancer immunotherapy [Internet]. Molecular Therapy - Oncolytics. 2020 ; 19 240-252.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.omto.2020.10.007Vancouver
Tzelepis F, Birdi HK, Jirovec A, Boscardin SB, Souza CT de, Hooshyar M, Chen A, Sutherland K, Parks RJ, Werier J, Diallo J-S. Oncolytic rhabdovirus vaccine boosts chimeric Anti-DEC205 priming for effective cancer immunotherapy [Internet]. Molecular Therapy - Oncolytics. 2020 ; 19 240-252.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.omto.2020.10.007
